The feasibility of a fully synthetic and self-assembled peptide solution as submucosal injection material: a preliminary animal study

Abstract

Background and aim

An injection solution is required to create a submucosal cushion (SMC) for safe endoscopic resection procedures. The aim of this preliminary animal study was to clarify the safety and efficacy of a novel fully synthetic and self-assembled peptide (FSSP) solution as a submucosal injection material (SMIM).

Method

To compare the submucosal-lifting properties, 0.3% FSSP, Eleview^®, sodium hyaluronate acid solution (SHA) and normal saline (NS) were randomly injected using an injection needle into the submucosa of exposed stomach and colon in five living dogs in a blind fashion. The mean height, and volume of SMCs were measured using a digital caliper immediately and 10, 20, 30, and 40 min after injecting each solution. All resected specimens were examined histopathologically.

Results

In both the colon and stomach, ANOVA for repeated measures showed the significant interaction between time and solution for the time-dependent change in the height. In the colon, FSSP created significantly higher SMC than NS 20 min after injection (p = .0015) and Eleview^® and NS 40 min after injection (p = .0009 and p = .0002). Furthermore, FSSP and SHA tended to maintain height and volume when compared to the other two solutions. In the stomach, FSSP and SHA tended to maintain height and volume when compared to the other two solutions. There were no significant differences between the histopathological finding and the injecting solutions used.

Conclusion

FSSP seems to be useful as a SMIM for endoscopic resection especially in the colon. Further studies are needed prior to clinical use of FSSP.

Keywords:

• Fully synthetic and self-assembled peptide solution
• submucosal injection material
• endoscopic mucosal resection
• endoscopic submucosal dissection
• preliminary animal study

Acknowledgment

We express our appreciation to Dr. Christopher Hayward for revision of the manuscript.

Disclosure statement

Dr. Uraoka has received a lecture fee from 3-D Matrix Ltd and is a consultant of 3D-Matrix.

Additional information

Funding

This work was supported by 3-D Matrix Ltd.